Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports.
Anticoagulation therapy
Asymptomatic disease
COVID-19
Deep vein thrombosis
Pulmonary embolism
Thromboinflammation
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
07
2020
accepted:
06
08
2020
entrez:
25
8
2020
pubmed:
25
8
2020
medline:
25
8
2020
Statut:
ppublish
Résumé
Scarce data exist regarding the clinical sequelae of COVID-19 and/or the prevalence of thromboembolic disease in asymptomatic patients. Surely, there is increased prevalence of thromboembolic disease and pulmonary embolism (PE) in critically ill patients with COVID-19; hence the administration of even enhanced thromboprophylaxis was suggested. However, the administration of regular thromboprophylaxis in asymptomatic outpatients is an entirely different matter. Herein, we present the clinical story of insidious PE development in two asymptomatic COVID-19 female patients. Issues regarding the pathogenesis of thromboembolism in COVID-19 and the clinical management are equally discussed.
Identifiants
pubmed: 32834989
doi: 10.1016/j.rmcr.2020.101186
pii: S2213-0071(20)30400-7
pii: 101186
pmc: PMC7418650
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101186Informations de copyright
© 2020 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280
pubmed: 32107577
J Am Coll Radiol. 2020 Jun;17(6):701-709
pubmed: 32283052
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32269100
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
J Ultrasound Med. 2020 Aug 14;:
pubmed: 32797661
Invest Radiol. 2020 May;55(5):257-261
pubmed: 32091414
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
JAMA Netw Open. 2020 May 1;3(5):e2010475
pubmed: 32463468
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Thromb Haemost. 2020 Mar;120(3):515-524
pubmed: 31975354
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Thorac Imaging. 2020 Jul;35(4):W97-W101
pubmed: 32235187
Crit Care. 2020 Jun 2;24(1):275
pubmed: 32487122
J Crit Care. 2020 Dec;60:328-333
pubmed: 32763058
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Ann Intern Med. 2020 Sep 1;173(5):394-395
pubmed: 32422061
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
Crit Care. 2020 Jun 2;24(1):274
pubmed: 32487231
ACS Chem Neurosci. 2020 Aug 5;11(15):2159-2162
pubmed: 32786343
JAMA. 2020 Aug 4;324(5):460-470
pubmed: 32492084
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267
pubmed: 32209890
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
J Gen Intern Med. 2020 Jul;35(7):2205-2206
pubmed: 32314129
J Infect. 2020 Apr;80(4):394-400
pubmed: 32109443
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304